Clare Heggie, Anna C Noonan, Chloë Fuller, Shelley McKibbon, Martha Paynter
{"title":"Sexual and reproductive health experiences and outcomes of incarcerated women and gender-diverse people in Australia: a scoping review.","authors":"Clare Heggie, Anna C Noonan, Chloë Fuller, Shelley McKibbon, Martha Paynter","doi":"10.1136/bmjsrh-2025-202903","DOIUrl":"10.1136/bmjsrh-2025-202903","url":null,"abstract":"<p><strong>Background: </strong>Women and gender-diverse people are a fast-growing population in prisons in Australia. Incarceration can create barriers to accessing sexual and reproductive healthcare. The objective of this scoping review was to identify what is known about the sexual and reproductive health experiences, needs and outcomes of women and gender-diverse people incarcerated in Australia.</p><p><strong>Methods: </strong>We used the Joanna Briggs Institute methodology for systematic scoping reviews. Databases searched included PsycINFO, Gender Studies Database, MEDLINE and CINAHL. The search yielded 658 titles and abstracts of which 17 met the criteria for inclusion.</p><p><strong>Results: </strong>We identified 17 studies published between 2000 and 2023 across three states. The studies included qualitative, quantitative and mixed-methods designs. The main outcomes of interest included: pregnancy and maternal health, contraception, sexually transmitted infections, experiences of sexual violence, and cervical health screening and outcomes.</p><p><strong>Conclusions: </strong>Evidence indicates that women and gender-diverse populations in prison in Australia experience high rates of sexually transmitted infections, poor perinatal health outcomes, and unmet needs related to contraception access and perinatal health services and programmes. The negative health impacts of incarceration are especially pronounced for Aboriginal and/or Torres Strait Islander women, who face additional discriminatory institutional barriers to participating in health programmes and experience a lack of culturally safe and appropriate care.</p>","PeriodicalId":9219,"journal":{"name":"BMJ Sexual & Reproductive Health","volume":" ","pages":"130-141"},"PeriodicalIF":2.8,"publicationDate":"2026-04-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145243728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Emily R Boniface, Blair G Darney, Agathe van Lamsweerde, Eleonora Benhar, Leo Han, Kristen Matteson, Victoria Male, Sharon Cameron, Alexandra Alvergne, Alison Edelman
{"title":"Association between menstrual cycle pattern regularity and changes in menstrual bleeding following COVID-19 vaccination: secondary analysis of an observational study.","authors":"Emily R Boniface, Blair G Darney, Agathe van Lamsweerde, Eleonora Benhar, Leo Han, Kristen Matteson, Victoria Male, Sharon Cameron, Alexandra Alvergne, Alison Edelman","doi":"10.1136/bmjsrh-2024-202564","DOIUrl":"10.1136/bmjsrh-2024-202564","url":null,"abstract":"","PeriodicalId":9219,"journal":{"name":"BMJ Sexual & Reproductive Health","volume":" ","pages":"161-162"},"PeriodicalIF":3.2,"publicationDate":"2026-04-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12206926/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142909302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The UK Medical Eligibility Criteria for Contraceptive Use (UKMEC).","authors":"","doi":"10.1136/bmjsrh-2026-UKMEC","DOIUrl":"https://doi.org/10.1136/bmjsrh-2026-UKMEC","url":null,"abstract":"","PeriodicalId":9219,"journal":{"name":"BMJ Sexual & Reproductive Health","volume":"52 Suppl 1","pages":"1-138"},"PeriodicalIF":2.8,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147608284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Free emergency contraception in pharmacies: a snapshot of local impact from Kirklees.","authors":"Kate Hamilton, Rebecca Gunn, Rebecca Strauss","doi":"10.1136/bmjsrh-2025-203138","DOIUrl":"https://doi.org/10.1136/bmjsrh-2025-203138","url":null,"abstract":"","PeriodicalId":9219,"journal":{"name":"BMJ Sexual & Reproductive Health","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2026-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147580548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Highlights from the literature.","authors":"","doi":"10.1136/bmjsrh-2025-203054","DOIUrl":"https://doi.org/10.1136/bmjsrh-2025-203054","url":null,"abstract":"","PeriodicalId":9219,"journal":{"name":"BMJ Sexual & Reproductive Health","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2026-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147430993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mikaela Koch, Song Hyun Kim, Pavithra Sundaravaradan, Hayoung E Ahn, Milan V Carter, Serinee H Tran, Maral Demirjian, Lorna Kwan, Aparna Sridhar
{"title":"Social media narratives regarding Opill®: public discourse analysis around the first over-the-counter birth control pill.","authors":"Mikaela Koch, Song Hyun Kim, Pavithra Sundaravaradan, Hayoung E Ahn, Milan V Carter, Serinee H Tran, Maral Demirjian, Lorna Kwan, Aparna Sridhar","doi":"10.1136/bmjsrh-2025-203093","DOIUrl":"https://doi.org/10.1136/bmjsrh-2025-203093","url":null,"abstract":"","PeriodicalId":9219,"journal":{"name":"BMJ Sexual & Reproductive Health","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2026-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146257442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Sexual and reproductive health clinical consultations: Contraception and HIV antiretroviral therapy.","authors":"Sian Pearson, Nadi Gupta","doi":"10.1136/bmjsrh-2024-202602","DOIUrl":"10.1136/bmjsrh-2024-202602","url":null,"abstract":"","PeriodicalId":9219,"journal":{"name":"BMJ Sexual & Reproductive Health","volume":" ","pages":"75-77"},"PeriodicalIF":2.8,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144688970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Johanna Rydelius, Helena Kopp Kallner, Ove Karlsson, Helena Hognert, Kristina Gemzell-Danielsson
{"title":"Pain management for medical abortion beyond 12 weeks of gestation: a cross-sectional study in Sweden.","authors":"Johanna Rydelius, Helena Kopp Kallner, Ove Karlsson, Helena Hognert, Kristina Gemzell-Danielsson","doi":"10.1136/bmjsrh-2024-202691","DOIUrl":"10.1136/bmjsrh-2024-202691","url":null,"abstract":"<p><strong>Background: </strong>Medical abortion beyond 12 weeks' gestation increases experienced pain. The effectiveness of pain management protocols remains to be evaluated.</p><p><strong>Methods: </strong>This was a secondary analysis of a randomised controlled trial, conducted in six Swedish hospitals from 2019 to 2022, investigating home administration of the first misoprostol dose. Paracetamol 1000 mg and a non-steroidal anti-inflammatory drug (NSAID) were provided with the first misoprostol dose and subsequent breakthrough pain medication as required. We recruited persons >18 years of age, with a viable singleton pregnancy between 12 weeks+1 day and 21 weeks+6 days of gestation. We collected data on patient-reported pain using a visual analogue scale (VAS, 0-100 mm) at fetal expulsion and maximum pain assessed retrospectively prior to discharge. We collected data on the use of breakthrough pain medication, satisfaction scores with pain relief, and VAS scores before/after administration of breakthrough analgesia.</p><p><strong>Results: </strong>We included 425 individuals. The participants reported a mean VAS of 39.1 (SD 34.4) at expulsion and 65.4 (SD 28.6) as maximum pain (assessed after abortion before discharge) and 352/425 (82.8%) received breakthrough pain medication, with 266/425 (62.6%) receiving an oral opioid, 163/425 (38.4%) a paracervical block (PCB) and 86/425 (20.2%) a parenteral opioid. A total of 357/392 (91.1%) participants were satisfied with the pain relief. Administration of a PCB alone or following an opioid resulted in the largest decrease in VAS.</p><p><strong>Conclusions: </strong>Many participants reported high VAS scores but most of them were satisfied with their analgesic treatment. A PCB was associated with the highest effectiveness in alleviating pain.</p>","PeriodicalId":9219,"journal":{"name":"BMJ Sexual & Reproductive Health","volume":" ","pages":"19-25"},"PeriodicalIF":2.8,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144820641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Understanding structural barriers to abortion care under the counselling regulation in Germany: results of a qualitative interview study.","authors":"Amelie Kolandt, Susanne Michl, Mirjam Faissner","doi":"10.1136/bmjsrh-2025-202798","DOIUrl":"10.1136/bmjsrh-2025-202798","url":null,"abstract":"<p><strong>Objective: </strong>Abortion care in Germany is under-researched. Available data show regional disparities in the availability and accessibility of abortion services, but the structural causes for this remain unclear. In Germany, abortion is technically illegal but is exempt from punishment under the counselling regulation, which means that the pregnant person has to undergo mandatory counselling and observe a 3-day waiting period. This qualitative interview study examines the perspectives of abortion care providers on the provision of abortion care under this regulation in Germany.</p><p><strong>Design: </strong>We included 42 gynaecologists and abortion counsellors nationwide. We conducted in-depth, guideline-based interviews that explored the participants' perspectives on challenges in abortion care. The data were analysed using qualitative content analysis according to Mayring. The results were evaluated against the WHO's components of the right to sexual and reproductive health: availability, accessibility, acceptability, quality, and equity, inclusivity and patient-centredness of care.</p><p><strong>Results: </strong>We identified various structural barriers that limit the availability, accessibility, acceptability and quality of abortion care under the counselling regulation in Germany. Interviewees named the shortage of doctors performing abortions as one structural root cause for insufficient abortion care that is exacerbated by the procedure's criminalisation. A lack of information transparency, complex legal requirements, language barriers, disinformation as well as social stigmatisation were cited as important barriers to abortion care. These barriers were described as having a particularly strong impact on patients from marginalised groups.</p><p><strong>Conclusions: </strong>Our study indicates that structural barriers associated with the current legal regulation create significant hurdles for both patients and providers and undermine the access, availability, acceptability, quality of care, and patient-centredness of care. In this context, we strongly support the recommendation of the German government's expert commission to revise the current legal regulation of abortion in Germany.</p>","PeriodicalId":9219,"journal":{"name":"BMJ Sexual & Reproductive Health","volume":" ","pages":"5-18"},"PeriodicalIF":2.8,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144943549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Elizabeth April Wheate, John Joseph Reynolds-Wright, Sharon T Cameron
{"title":"Early medical abortion before missed menses: outcomes of abortion at less than 30 days from last menstrual period.","authors":"Elizabeth April Wheate, John Joseph Reynolds-Wright, Sharon T Cameron","doi":"10.1136/bmjsrh-2024-202534","DOIUrl":"10.1136/bmjsrh-2024-202534","url":null,"abstract":"<p><strong>Introduction: </strong>High-sensitivity urine pregnancy tests can detect pregnancy before missed menses. The widespread availability of these tests, alongside improvements in abortion access in many settings, may mean more women present for abortion at a very early stage of pregnancy. We aimed to examine the outcome of early medical abortion (EMA) in pregnancies less than 30 days from last menstrual period (LMP).</p><p><strong>Methods: </strong>This study analysed prospectively collected data on patients at less than 30 days from LMP seeking abortion at a single service in Edinburgh, UK between March 2020 and December 2023. We determined the effectiveness, outcomes of the pregnancy (complete abortion, ongoing pregnancy, incomplete abortion) and serious complications among those seeking EMA at this gestation.</p><p><strong>Results: </strong>Of 13 565 patients seeking abortion, 78 (0.6%) presented with a self-reported positive home pregnancy test and less than 30 days from LMP. Some 63/78 patients (81%) proceeded to EMA with mifepristone followed by misoprostol. Of this group, 31/63 (49%) had a pre-abortion ultrasound. Complete abortion occurred in 58/63 (92%, 95% CI 82% to 97%), 4/63 (6%) had an ongoing pregnancy and 1 (1%) had a surgical evacuation for incomplete abortion. There were no serious complications.</p><p><strong>Conclusions: </strong>Only a very small percentage of patients present for abortion before a missed period. Nevertheless, EMA at this stage is safe and effective. There may be a higher rate of ongoing pregnancy, and so those patients wishing to proceed to EMA should be advised of the importance of confirming success in line with local protocols.</p>","PeriodicalId":9219,"journal":{"name":"BMJ Sexual & Reproductive Health","volume":" ","pages":"32-37"},"PeriodicalIF":2.8,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143482228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}